Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical Hodgkin lymphoma: A multicenter, single-arm, phase II study
Ningjing Lin, Mingzhi Zhang, Hai Bai et al. · European Journal of Cancer · 2021
Cited by 48Open access